French medtech startup BCV bags €6M: Know more
Paris-based BCV (Basecamp Vascular), a medtech company, announced on Wednesday that it has secured €6M in a Series A round of financing led…
Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
698 articles · Health Tech & Medtech
Paris-based BCV (Basecamp Vascular), a medtech company, announced on Wednesday that it has secured €6M in a Series A round of financing led…
Lausanne, Switzerland-based Aesyra, a medical device company that develops oral appliance technologies to improve sleep, announced that it…
Paris-based Spore.bio, the deeptech startup behind the world’s first real-time pathogen detection device for factories, announced on Tuesday that it has secured €8M in a pre-seed round of funding.
A “state-of-the-art” business campus in Luxembourg, HE:AL Campus, is seeking €250M in investments.
London-based startup Phare Health has secured £2.5M (approximately €2.87M) in a seed round of funding led by General Catalyst.
London-based Doccla, a provider of virtual hospital technology, announced on Tuesday that it has closed €5M from Bertelsmann Investments, the global venture capital arm of Bertelsmann Corporation.
Gothenburg, Sweden-based Texray, a company specialised in radiation protection textiles, announced on Tuesday that it has secured SEK 45M…
Leiden-based RespiQ, a health tech startup, announced on Monday, November 20, that it has been awarded a €4M grant from the European…
Amsterdam-based VectorY Therapeutics, a biotech company, announced on Monday that it has secured €129M in a Series A round of funding co-led by EQT Life Sciences and the Forbion Growth Opportunities Fund.
Berlin-based healthtech startup doctorly, announced that it has secured a $7.2M (nearly €6.72M) extension to its Series A funding round…
Leiden-based Artica Therapeutics, a biotechnology company, announced on Thursday, November 2 that it has secured €12M in a seed round of funding.
UK biotech firm ImmuOne secures €2.2M investment to transform drug testing, replacing animals with innovative 3D lung models.